Estimations des analystes de Wall Street pour Cigna Corporation (CI): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-10-29 | $7.51 | ||
| 2026-07-30 | $7.78 | $7.60 | +2.4% |
| 2026-04-30 | $7.79 | $7.60 | +2.5% |
| 2026-02-05 | $8.08 | $7.88 | +2.5% |
| 2025-10-30 | $7.83 | $7.64 | +2.5% |
| 2025-07-31 | $7.20 | $7.16 | +0.6% |
| 2025-05-02 | $6.74 | $6.35 | +6.1% |
| 2025-01-30 | $6.64 | $7.84 | -15.3% |
Ratios de valorisation
| Ratio P/E | 11.35 |
| Prix / Valeur comptable | 1.70 |
| EV / EBITDA | 8.36 |
| Rendement du dividende | 2.25% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $39.84B | $41.81B | $48.65B | $153.57B | $160.40B | $174.07B | $180.52B | $195.26B | $247.12B | $274.95B |
| Coût des Ventes | $26.81B | $27.72B | $32.32B | $128.49B | $136.19B | $151.12B | $157.02B | $170.09B | $221.16B | $248.97B |
| Marge Brute | $13.03B | $14.09B | $16.33B | $25.08B | $24.21B | $22.95B | $23.50B | $25.18B | $25.96B | $25.99B |
| R&D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Frais Généraux | $9.63B | $9.85B | $11.23B | $13.31B | $13.66B | $12.79B | $13.04B | $14.32B | $14.57B | $14.00B |
| Charges Opérationnelles | $9.94B | $10.14B | $12.17B | $17.00B | $16.05B | $15.01B | $15.05B | $16.64B | $16.55B | $16.86B |
| Résultat Opérationnel | $3.09B | $3.94B | $4.16B | $8.08B | $8.15B | $7.94B | $8.45B | $8.54B | $9.42B | $9.13B |
| EBITDA | $3.54B | $4.38B | $5.22B | $11.58B | $10.37B | $9.96B | $10.44B | $10.85B | $11.45B | $11.61B |
| Charges d'Intérêt | $278.0M | $252.0M | $498.0M | $1.68B | $1.44B | $1.21B | $1.23B | $1.45B | $1.44B | $1.38B |
| Résultat Avant Impôts | $2.98B | $3.61B | $3.58B | $6.57B | $10.87B | $6.79B | $8.40B | $5.51B | $5.27B | $7.59B |
| Impôts | $1.14B | $1.37B | $935.0M | $1.45B | $2.38B | $1.37B | $1.61B | $141.0M | $1.49B | $1.34B |
| Résultat Net | $1.87B | $2.24B | $2.64B | $5.10B | $8.46B | $5.37B | $6.70B | $5.16B | $3.43B | $5.96B |
| BPA | $7.31 | $9.17 | $10.69 | $13.58 | $23.17 | $15.89 | $21.66 | $17.57 | $12.25 | $22.30 |
| BPA Dilué | $7.19 | $9.17 | $10.54 | $13.44 | $22.96 | $15.75 | $21.41 | $17.39 | $12.12 | $22.17 |
| Actions en Circulation (Diluées) | $259.6M | $244.0M | $246.7M | $379.8M | $368.4M | $341.0M | $313.1M | $296.9M | $283.2M | $265.9M |
Prix
| Prix | $275.28 |
| Capitalisation | $72.7B |
| Bourse | NYSE |
| Pays | US |
Entreprises liées: BDX · CAH · CNC · COR · CVS · ELV · HUM
Explorer le secteur: Healthcare · Medical - Healthcare Plans
Plus de sections de CI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions